Polymerization of fibrin: Specificity, strength, and stability of knob-hole interactions studied at the single-molecule level

Blood

Volumn 106, Issue 9, 2005, Pages 2944-2951

  Litvinov, Rustem I ^a   Gorkun, Oleg V ^b   Owen, Scott F ^b   Shuman, Henry ^b   Weisel, John W ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DISULFIDE; FIBRIN; FIBRINOGEN; GLYCYLHISTIDYLARGINYLPROLINE; GLYCYLPROLYLARGINYLPROLINE; PEPTIDE DERIVATIVE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BINDING AFFINITY; COMPARATIVE STUDY; CONTROLLED STUDY; FIBRIN POLYMERIZATION; MOLECULAR MIMICRY; MOLECULE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN STRUCTURE; SENSITIVITY ANALYSIS; STATISTICAL SIGNIFICANCE;

EID: 27644526146     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2005-05-2039     Document Type: Article

References (47)

1. Pratt KP, Cote HC, Chung DW, Stenkamp RE, Davie EW. The primary fibrin polymerization pocket: three-dimensional structure of a 30-kDa C-terminal gamma chain fragment complexed with the peptide Gly-Pro-Arg-Pro. Proc Natl Acad Sci U S A. 1997;94:7176-7181.
2. Spraggon G, Everse SJ, Doolittle RF. Crystal structures of fragment D from human fibrinogen and its crosslinked counterpart from fibrin. Nature. 1997;389:455-462.
3. Doolittle RF. Fibrinogen and fibrin. In: Bloom AL, Thomas DP, eds. Haemostasis and Thrombosis. New York, NY: Churchill Livingstone; 1981:163-191.
4. Weisel JW. Fibrinogen and fibrin. Adv Protein Chem. 2005;70:247-299.
5. Weisel JW, Veklich Y, Gorkun O. The sequence of cleavage of fibrinopeptides from fibrinogen is important for protofibril formation and enhancement of lateral aggregation in fibrin clots. J Mol Biol. 1993;232:285-297.
6. Laudano AP, Cottrell BA, Doolittle RF. Synthetic peptides modeled on fibrin polymerization sites. Ann N Y Acad Sci. 1983;408:315-329.
7. Lewis SD, Shields PP, Shafer JA. Characterization of the kinetic pathway for liberation of fibrinopeptides during assembly of fibrin. J Biol Chem. 1985;260:10192-10199.
8. Ruf W, Bender A, Lane DA, Preissner KT, Selmayr E, Muller-Berghaus G. Thrombin-induced fibrinopeptide B release from normal and variant fibrinogens: influence of inhibitors of fibrin polymerization. Biochim Biophys Acta. 1988;965:169-175.
9. Everse SJ, Spraggon G, Veerapandian L, Riley M, Doolittle RF. Crystal structure of fragment double-D from human fibrin with two different bound ligands. Biochemistry. 1998;37:8637-8642.
10. Laudano AP, Doolittle RF. Studies on synthetic peptides that bind to fibrinogen and prevent fibrin polymerization. Structural requirements, number of binding sites, and species differences. Biochemistry. 1980;19:1013-1019.
11. Shainoff JR, Dardik BN. Fibrinopeptide B and aggregation of fibrinogen. Science. 1979;204:200-202.
12. Weisel JW. Fibrin assembly. Lateral aggregation and the role of the two pairs of fibrinopeptides. Biophys J. 1986;50:1079-1093.
13. Mosesson MW, DiOrio JP, Muller MF, et al. Studies on the ultrastructure of fibrin lacking fibrinopeptide B (beta-fibrin). Blood. 1987;69:1073-1081.
14. Hogan KA, Bolliger B, Okumura N, Lord ST. The formation of beta fibrin requires a functional a site. Ann N Y Acad Sci. 2001;936:219-222.
15. Blomback B, Hessel B, Hogg D, Therkildsen L. A two-step fibrinogen-fibrin transition in blood coagulation. Nature. 1978;275:501-505.
16. Weisel JW, Medved L. The structure and function of the alpha C domains of fibrinogen. Ann N Y Acad Sci. 2001;936:312-327.
17. Yang Z, Mochalkin I, Doolittle RF. A model of fibrin formation based on crystal structures of fibrinogen and fibrin fragments complexed with synthetic peptides. Proc Natl Acad Sci U S A. 2000;97:14156-14161.
18. Gorkun OV, Veklich YI, Weisel JW, Lord ST. The conversion of fibrinogen to fibrin: recombinant fibrinogen typifies plasma fibrinogen. Blood. 1997;89:4407-4414.
19. Kostelansky MS, Betts L, Gorkun OV, Lord ST. 2.8 A crystal structures of recombinant fibrinogen fragment D with and without two peptide ligands: GHRP binding to the "b" site disrupts its nearby calcium-binding site. Biochemistry. 2002;41:12124-12132.
20. Blomback B, Hessel B, Iwanaga S, Reuterby J, Blomback M. Primary structure of human fibrinogen and fibrin, I: Cleavage of fibrinogen with cyanogen bromide. Isolation and characterization of NH 2 -terminal fragments of the ("A") chain. J Biol Chem. 1972;247:1496-1512.
21. 2- terminal part of human fibrinogen. Thromb Res. 1976;8:639-658.
22. Kudryk BJ, Collen D, Woods KR, Blomback B. Evidence for localization of polymerization sites in fibrinogen. J Biol Chem. 1974;249:3322-3325.
23. York LL, Blomback B. Interaction of fragments of fibrinogen with insolubilized fibrin monomers (activated fibrinogen). Thromb Res. 1976;8:607-618.
24. Olexa SA, Budzynski AZ. Binding phenomena of isolated unique plasmic degradation products of human cross-linked fibrin. J Biol Chem. 1979;254:4925-4932.
25. Litvinov RI, Shuman H, Bennett JS, Weisel JW. Binding strength and activation state of single fibrinogen-integrin pairs on living cells. Proc Natl Acad Sci U S A. 2002;99:7426-7431.
26. Bell GI. Models for the specific adhesion of cells to cells. Science. 1978;200:618-627.
27. Evans E, Ritchie K. Dynamic strength of molecular adhesion bonds. Biophys J. 1997;72:1541-1555.
28. Tees DFJ, Woodward JT, Hammer D. Reliability theory for receptor-ligand bond dissociation. J Chem Phys. 2001;114:7483-7496.
29. Litvinov RI, Vilaire G, Shuman H, Bennett JS, Weisel JW. Quantitative analysis of platelet alpha v beta 3 binding to osteopontin using laser tweezers. J Biol Chem. 2003;278:51285-51290.
30. Zhu C, Long M, Chesla SE, Bongrand P. Measuring receptor/ligand interaction at the single-bond level: experimental and interpretative issues. Ann Biomed Eng. 2002;30:305-314.
31. Medved L, Ugarova T, Veklich Y, Lukinova N, Weisel J. Electron microscope investigation of the early stages of fibrin assembly. Twisted protofi-brils and fibers. J Mol Biol. 1990;216:503-509.
32. Veklich YI, Gorkun OV, Medved LV, Nieuwenhuizen W, Weisel JW. Carboxyl-terminal portions of the alpha chains of fibrinogen and fibrin. Localization by electron microscopy and the effects of isolated alpha C fragments on polymerization. J Biol Chem. 1993;268:13577-13585.
33. Gorkun OV, Veklich YI, Medved LV, Henschen AH, Weisel JW. Role of the alpha C domains of fibrin in clot formation. Biochemistry. 1994;33:6986-6997.
34. Yang Z, Spraggon G, Pandi L, Everse SJ, Riley M, Doolittle RF. Crystal structure of fragment D from lamprey fibrinogen complexed with the peptide Gly-His-Arg-Pro-amide. Biochemistry. 2002;41:10218-10224.
35. Pandya BV, Gabriel JL, O'Brien J, Budzynski AZ. Polymerization site in the beta chain of fibrin: mapping of the B beta 1-55 sequence. Biochemistry. 1991;30:162-168.
36. Medved L, Tsurupa G, Yakovlev S. Conformational changes upon conversion of fibrinogen into fibrin. The mechanisms of exposure of cryptic sites. Ann N Y Acad Sci. 2001;936:185-204.
37. Litvinov RI, Bennett JS, Weisel JW, Shuman H. Multi-step fibrinogen binding to the integrin αIIbβ3 detected using force spectroscopy. Biophys J. Prepublished on July 22, 2005, as DOI 10.1529/biophysj. 105.061887.
38. Weisel JW, Shuman H, Litvinov RI. Protein-protein unbinding induced by force: single-molecule studies. Curr Opin Struct Biol. 2003;13:227-235.
39. Merkel R, Nassoy P, Leung A, Ritchie K, Evans E. Energy landscapes of receptor-ligand bonds explored with dynamic force spectroscopy. Nature. 1999;397:50-53.
40. Lorthois S, Schmitz P, Angles-Cano E. Experimental study of fibrin/fibrin-specific molecular interactions using a sphere/plane adhesion model. J Colloid Interface Sci. 2001;241:52-62.
41. Chilkoti A, Stayton PS. Molecular origins of the slow streptavidin-biotin dissociation kinetics. J Am Chem Soc. 1995;117:10622-10628.
42. Evans E. Looking inside molecular bonds at biological interfaces with dynamic force spectroscopy. Biophys Chem. 1999;82:83-97.
43. Rinko LJ, Lawrence MB, Guilford WH. The molecular mechanics of P- and L-selectin lectin domains binding to PSGL-1. Biophys J. 2004;86:544-554.
44. Carr ME Jr. Development of platelet contractile force as a research and clinical measure of platelet function. Cell Biochem Biophys. 2003;38:55-78.
45. Scrutton MC, Ross-Murphy SB, Bennett GM, Stirling Y, Meade TW. Changes in clot deformability: a possible explanation for the epidemiological association between plasma fibrinogen concentration and myocardial infarction. Blood Coagul Fibrinolysis. 1994;5:719-723.
46. Ksander GA, Vistnes LM, Rose EH. Excisional wound biomechanics, skin tension lines, and elastic contraction. Plast Reconstr Surg. 1977;59:398-406.
47. Turitto VT, Hall CL. Mechanical factors affecting hemostasis and thrombosis. Thromb Res. 1998;92:S25-31.